| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Semen Analysis | 46 | 2023 | 236 | 8.860 |
Why?
|
| Pesticide Residues | 16 | 2023 | 95 | 6.630 |
Why?
|
| Infertility | 32 | 2024 | 655 | 6.380 |
Why?
|
| Infertility, Female | 39 | 2024 | 763 | 5.550 |
Why?
|
| Diabetes, Gestational | 46 | 2024 | 1263 | 5.230 |
Why?
|
| Hypertension, Pregnancy-Induced | 12 | 2024 | 529 | 5.060 |
Why?
|
| Fertility | 30 | 2023 | 771 | 4.870 |
Why?
|
| Sperm Count | 25 | 2023 | 228 | 4.190 |
Why?
|
| Reproductive Techniques, Assisted | 29 | 2022 | 504 | 3.770 |
Why?
|
| Diet | 74 | 2024 | 8087 | 3.640 |
Why?
|
| Menstrual Cycle | 11 | 2024 | 546 | 3.430 |
Why?
|
| Abortion, Spontaneous | 12 | 2023 | 534 | 3.410 |
Why?
|
| Pregnancy | 178 | 2024 | 30260 | 3.240 |
Why?
|
| Spermatozoa | 20 | 2020 | 632 | 3.010 |
Why?
|
| Nurses | 26 | 2024 | 2501 | 2.990 |
Why?
|
| Vegetables | 19 | 2023 | 1199 | 2.930 |
Why?
|
| Fruit | 19 | 2023 | 1165 | 2.870 |
Why?
|
| Semen | 16 | 2023 | 349 | 2.870 |
Why?
|
| Infertility, Male | 17 | 2020 | 397 | 2.850 |
Why?
|
| Dietary Fats | 19 | 2022 | 2001 | 2.800 |
Why?
|
| Pre-Eclampsia | 11 | 2024 | 1257 | 2.790 |
Why?
|
| Body Mass Index | 69 | 2025 | 13053 | 2.770 |
Why?
|
| Prospective Studies | 192 | 2024 | 54924 | 2.590 |
Why?
|
| Preconception Care | 10 | 2021 | 143 | 2.420 |
Why?
|
| Trans Fatty Acids | 7 | 2022 | 155 | 2.360 |
Why?
|
| Pesticides | 11 | 2023 | 298 | 2.280 |
Why?
|
| Menstruation Disturbances | 5 | 2021 | 143 | 2.240 |
Why?
|
| Fertilization in Vitro | 24 | 2023 | 1303 | 2.240 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 11 | 2024 | 395 | 2.170 |
Why?
|
| Ovulation | 8 | 2016 | 181 | 2.040 |
Why?
|
| Dairy Products | 12 | 2019 | 490 | 2.040 |
Why?
|
| Pregnancy Outcome | 26 | 2024 | 2972 | 2.030 |
Why?
|
| Sperm Motility | 18 | 2023 | 265 | 2.000 |
Why?
|
| Overweight | 20 | 2024 | 2448 | 1.980 |
Why?
|
| Cesarean Section | 8 | 2024 | 1425 | 1.950 |
Why?
|
| Anti-Mullerian Hormone | 10 | 2025 | 420 | 1.870 |
Why?
|
| Diet Surveys | 20 | 2021 | 1160 | 1.840 |
Why?
|
| Soy Foods | 4 | 2016 | 44 | 1.790 |
Why?
|
| Live Birth | 18 | 2021 | 516 | 1.780 |
Why?
|
| Diabetes Mellitus, Type 2 | 30 | 2024 | 12252 | 1.780 |
Why?
|
| Feeding Behavior | 24 | 2024 | 3205 | 1.770 |
Why?
|
| Adult | 244 | 2025 | 223583 | 1.630 |
Why?
|
| Female | 314 | 2025 | 397113 | 1.590 |
Why?
|
| Environmental Pollutants | 13 | 2024 | 1296 | 1.550 |
Why?
|
| Reproduction | 9 | 2023 | 646 | 1.540 |
Why?
|
| Seafood | 7 | 2018 | 395 | 1.480 |
Why?
|
| Caffeine | 7 | 2018 | 703 | 1.450 |
Why?
|
| Menarche | 9 | 2023 | 538 | 1.440 |
Why?
|
| Risk Factors | 124 | 2024 | 74936 | 1.420 |
Why?
|
| Obesity | 35 | 2025 | 13091 | 1.410 |
Why?
|
| Occupational Exposure | 11 | 2021 | 1807 | 1.400 |
Why?
|
| Humans | 399 | 2025 | 767991 | 1.380 |
Why?
|
| Pregnancy Rate | 20 | 2022 | 655 | 1.370 |
Why?
|
| Meat | 6 | 2019 | 588 | 1.370 |
Why?
|
| Folic Acid | 12 | 2021 | 1337 | 1.360 |
Why?
|
| Dietary Supplements | 23 | 2024 | 3445 | 1.350 |
Why?
|
| Endometriosis | 14 | 2024 | 873 | 1.310 |
Why?
|
| Agaricales | 2 | 2019 | 30 | 1.310 |
Why?
|
| Cohort Studies | 72 | 2025 | 41749 | 1.300 |
Why?
|
| Fatty Acids | 9 | 2023 | 1811 | 1.300 |
Why?
|
| Life Style | 21 | 2024 | 3932 | 1.280 |
Why?
|
| Sweetening Agents | 6 | 2022 | 290 | 1.270 |
Why?
|
| Premature Birth | 5 | 2024 | 1829 | 1.260 |
Why?
|
| Adiposity | 9 | 2024 | 1895 | 1.250 |
Why?
|
| Coffee | 5 | 2024 | 594 | 1.190 |
Why?
|
| Follicle Stimulating Hormone | 11 | 2023 | 727 | 1.150 |
Why?
|
| Fatty Acids, Omega-3 | 9 | 2022 | 1399 | 1.150 |
Why?
|
| Anovulation | 6 | 2016 | 54 | 1.110 |
Why?
|
| Phenols | 8 | 2023 | 526 | 1.090 |
Why?
|
| Weight Gain | 11 | 2024 | 2359 | 1.080 |
Why?
|
| Delivery, Obstetric | 4 | 2021 | 954 | 1.080 |
Why?
|
| Sexual Behavior | 11 | 2024 | 2197 | 1.080 |
Why?
|
| Environmental Exposure | 18 | 2023 | 4543 | 1.070 |
Why?
|
| Eating | 7 | 2019 | 1542 | 1.050 |
Why?
|
| Polycystic Ovary Syndrome | 3 | 2025 | 383 | 1.030 |
Why?
|
| Phthalic Acids | 8 | 2023 | 487 | 1.010 |
Why?
|
| Fluorocarbons | 4 | 2024 | 506 | 1.000 |
Why?
|
| Vitamins | 10 | 2024 | 1638 | 0.970 |
Why?
|
| Menopause | 6 | 2024 | 1656 | 0.960 |
Why?
|
| Disinfectants | 3 | 2021 | 129 | 0.960 |
Why?
|
| Adolescent | 83 | 2024 | 89155 | 0.950 |
Why?
|
| Cannabis | 3 | 2023 | 446 | 0.940 |
Why?
|
| Carbonated Beverages | 5 | 2022 | 210 | 0.940 |
Why?
|
| Young Adult | 79 | 2024 | 60048 | 0.940 |
Why?
|
| Fertilization | 2 | 2023 | 197 | 0.940 |
Why?
|
| Prostatic Neoplasms | 14 | 2019 | 11101 | 0.910 |
Why?
|
| Diet, Mediterranean | 12 | 2024 | 746 | 0.890 |
Why?
|
| Waist Circumference | 5 | 2022 | 935 | 0.890 |
Why?
|
| Meat Products | 2 | 2014 | 97 | 0.890 |
Why?
|
| Pregnancy Complications | 10 | 2024 | 2972 | 0.870 |
Why?
|
| Cardiovascular Diseases | 15 | 2024 | 15660 | 0.870 |
Why?
|
| Ovarian Follicle | 9 | 2023 | 244 | 0.860 |
Why?
|
| Fatty Acids, Monounsaturated | 4 | 2022 | 190 | 0.860 |
Why?
|
| Male | 155 | 2024 | 364641 | 0.840 |
Why?
|
| Endocrine Disruptors | 2 | 2023 | 265 | 0.840 |
Why?
|
| Infant, Low Birth Weight | 2 | 2024 | 871 | 0.820 |
Why?
|
| Sperm Injections, Intracytoplasmic | 7 | 2021 | 156 | 0.820 |
Why?
|
| Beverages | 8 | 2024 | 819 | 0.810 |
Why?
|
| Gonadal Steroid Hormones | 5 | 2018 | 707 | 0.810 |
Why?
|
| Nutrition Assessment | 7 | 2015 | 740 | 0.810 |
Why?
|
| Food Contamination | 2 | 2023 | 193 | 0.790 |
Why?
|
| Birth Weight | 9 | 2024 | 2121 | 0.780 |
Why?
|
| Testosterone | 6 | 2025 | 2491 | 0.780 |
Why?
|
| Marijuana Smoking | 3 | 2019 | 261 | 0.770 |
Why?
|
| Parity | 9 | 2025 | 931 | 0.770 |
Why?
|
| beta Carotene | 2 | 2019 | 523 | 0.750 |
Why?
|
| Menopause, Premature | 1 | 2022 | 124 | 0.740 |
Why?
|
| Longitudinal Studies | 28 | 2024 | 14783 | 0.730 |
Why?
|
| Denmark | 12 | 2021 | 776 | 0.730 |
Why?
|
| Stillbirth | 2 | 2014 | 381 | 0.730 |
Why?
|
| Testis | 3 | 2020 | 783 | 0.720 |
Why?
|
| Fathers | 4 | 2024 | 377 | 0.710 |
Why?
|
| Incidence | 34 | 2024 | 21532 | 0.710 |
Why?
|
| Exercise | 13 | 2024 | 5955 | 0.710 |
Why?
|
| Prenatal Exposure Delayed Effects | 9 | 2024 | 2538 | 0.700 |
Why?
|
| Child Abuse | 4 | 2024 | 1091 | 0.690 |
Why?
|
| Intention | 1 | 2023 | 347 | 0.690 |
Why?
|
| Maternal Mortality | 1 | 2023 | 310 | 0.680 |
Why?
|
| Nutritional Status | 6 | 2021 | 1628 | 0.670 |
Why?
|
| Body Weight | 15 | 2024 | 4628 | 0.670 |
Why?
|
| Diethylhexyl Phthalate | 5 | 2023 | 86 | 0.660 |
Why?
|
| Self Report | 16 | 2024 | 3773 | 0.650 |
Why?
|
| Guillain-Barre Syndrome | 1 | 2020 | 127 | 0.640 |
Why?
|
| Proportional Hazards Models | 23 | 2024 | 12536 | 0.640 |
Why?
|
| Sexual Maturation | 2 | 2019 | 258 | 0.640 |
Why?
|
| Homosexuality, Female | 5 | 2021 | 171 | 0.640 |
Why?
|
| Paternal Exposure | 2 | 2019 | 100 | 0.630 |
Why?
|
| Middle Aged | 94 | 2024 | 223422 | 0.630 |
Why?
|
| Fishes | 6 | 2018 | 606 | 0.620 |
Why?
|
| Benzhydryl Compounds | 5 | 2022 | 944 | 0.620 |
Why?
|
| United States | 68 | 2024 | 73027 | 0.620 |
Why?
|
| Reproductive History | 2 | 2023 | 210 | 0.620 |
Why?
|
| Lifting | 2 | 2017 | 56 | 0.620 |
Why?
|
| Mothers | 11 | 2024 | 2209 | 0.610 |
Why?
|
| Work Schedule Tolerance | 4 | 2024 | 553 | 0.610 |
Why?
|
| Heterosexuality | 7 | 2024 | 309 | 0.590 |
Why?
|
| Neoplasms | 13 | 2023 | 22365 | 0.590 |
Why?
|
| Clothing | 1 | 2018 | 96 | 0.590 |
Why?
|
| Occupational Diseases | 4 | 2019 | 1457 | 0.590 |
Why?
|
| Pyrethrins | 1 | 2017 | 47 | 0.580 |
Why?
|
| Coitus | 1 | 2018 | 132 | 0.570 |
Why?
|
| Pregnancy, Ectopic | 1 | 2018 | 145 | 0.560 |
Why?
|
| Child | 55 | 2024 | 80906 | 0.560 |
Why?
|
| Erectile Dysfunction | 1 | 2020 | 437 | 0.550 |
Why?
|
| Birth Intervals | 1 | 2017 | 55 | 0.550 |
Why?
|
| Longevity | 4 | 2024 | 1078 | 0.550 |
Why?
|
| Dietary Proteins | 6 | 2018 | 960 | 0.550 |
Why?
|
| Adiponectin | 6 | 2025 | 1117 | 0.540 |
Why?
|
| Cognition | 2 | 2024 | 7072 | 0.540 |
Why?
|
| Antioxidants | 5 | 2019 | 1674 | 0.540 |
Why?
|
| Fetal Development | 2 | 2021 | 779 | 0.540 |
Why?
|
| Phospholipids | 1 | 2020 | 785 | 0.540 |
Why?
|
| Cross-Sectional Studies | 33 | 2024 | 26375 | 0.540 |
Why?
|
| Body Composition | 4 | 2022 | 2462 | 0.530 |
Why?
|
| Follow-Up Studies | 38 | 2022 | 39345 | 0.530 |
Why?
|
| Ascorbic Acid | 1 | 2019 | 658 | 0.530 |
Why?
|
| Linear Models | 15 | 2024 | 5884 | 0.520 |
Why?
|
| Cause of Death | 4 | 2024 | 3720 | 0.520 |
Why?
|
| Sodium, Dietary | 1 | 2020 | 426 | 0.520 |
Why?
|
| Dietary Carbohydrates | 5 | 2022 | 896 | 0.520 |
Why?
|
| Vitamin E | 1 | 2020 | 874 | 0.520 |
Why?
|
| Pregnancy Complications, Cardiovascular | 1 | 2020 | 519 | 0.520 |
Why?
|
| Weight Loss | 6 | 2023 | 2721 | 0.510 |
Why?
|
| Alcohol Drinking | 8 | 2021 | 4045 | 0.500 |
Why?
|
| Vitamin B Complex | 3 | 2019 | 299 | 0.500 |
Why?
|
| Hypercholesterolemia | 1 | 2022 | 1145 | 0.500 |
Why?
|
| Infant, Newborn | 21 | 2024 | 26420 | 0.500 |
Why?
|
| Air Pollutants | 8 | 2023 | 2915 | 0.490 |
Why?
|
| Diet Records | 4 | 2020 | 425 | 0.490 |
Why?
|
| Genital Diseases, Female | 1 | 2016 | 192 | 0.480 |
Why?
|
| Television | 4 | 2014 | 410 | 0.480 |
Why?
|
| Fetal Mortality | 1 | 2014 | 19 | 0.480 |
Why?
|
| Self-Assessment | 1 | 2017 | 400 | 0.470 |
Why?
|
| Functional Food | 1 | 2014 | 19 | 0.460 |
Why?
|
| Outpatient Clinics, Hospital | 2 | 2014 | 392 | 0.460 |
Why?
|
| Work | 1 | 2015 | 195 | 0.460 |
Why?
|
| Air Pollution | 8 | 2023 | 2374 | 0.460 |
Why?
|
| Diet, Vegetarian | 1 | 2016 | 181 | 0.450 |
Why?
|
| Sexual Partners | 2 | 2019 | 805 | 0.450 |
Why?
|
| Mental Recall | 3 | 2017 | 1226 | 0.440 |
Why?
|
| Follicular Fluid | 3 | 2023 | 92 | 0.430 |
Why?
|
| Autistic Disorder | 4 | 2024 | 1240 | 0.420 |
Why?
|
| Puberty | 3 | 2022 | 501 | 0.420 |
Why?
|
| Women's Health | 4 | 2017 | 2082 | 0.410 |
Why?
|
| Hypertension | 8 | 2024 | 8616 | 0.410 |
Why?
|
| Risk | 18 | 2021 | 9609 | 0.400 |
Why?
|
| Isoflavones | 2 | 2015 | 139 | 0.400 |
Why?
|
| Parabens | 3 | 2023 | 118 | 0.400 |
Why?
|
| Massachusetts | 12 | 2025 | 8888 | 0.400 |
Why?
|
| Endometrial Neoplasms | 1 | 2022 | 1382 | 0.400 |
Why?
|
| Coronary Disease | 3 | 2024 | 5919 | 0.400 |
Why?
|
| Multivariate Analysis | 16 | 2019 | 12075 | 0.400 |
Why?
|
| Odds Ratio | 18 | 2022 | 9666 | 0.390 |
Why?
|
| Dietary Fiber | 3 | 2022 | 767 | 0.380 |
Why?
|
| Lipogenesis | 1 | 2013 | 217 | 0.380 |
Why?
|
| Fatty Acids, Unsaturated | 4 | 2017 | 542 | 0.380 |
Why?
|
| Mercury | 3 | 2021 | 289 | 0.370 |
Why?
|
| Smoking | 9 | 2023 | 9089 | 0.370 |
Why?
|
| Bisexuality | 4 | 2021 | 295 | 0.370 |
Why?
|
| Insulin Resistance | 4 | 2021 | 3986 | 0.370 |
Why?
|
| Alkanesulfonic Acids | 3 | 2024 | 203 | 0.370 |
Why?
|
| Anxiety | 8 | 2024 | 4672 | 0.360 |
Why?
|
| Confidence Intervals | 6 | 2016 | 2923 | 0.360 |
Why?
|
| Blood Glucose | 6 | 2021 | 6429 | 0.360 |
Why?
|
| Citrus sinensis | 2 | 2020 | 15 | 0.350 |
Why?
|
| Data Collection | 3 | 2020 | 3326 | 0.350 |
Why?
|
| Hormones | 1 | 2014 | 866 | 0.340 |
Why?
|
| Birth Order | 2 | 2023 | 93 | 0.340 |
Why?
|
| Research Design | 6 | 2023 | 6211 | 0.340 |
Why?
|
| Blood Pressure | 3 | 2024 | 8540 | 0.330 |
Why?
|
| Vehicle Emissions | 3 | 2019 | 651 | 0.330 |
Why?
|
| Oocyte Retrieval | 5 | 2020 | 162 | 0.330 |
Why?
|
| Embryo Implantation | 4 | 2021 | 272 | 0.320 |
Why?
|
| Embryo Transfer | 4 | 2020 | 527 | 0.320 |
Why?
|
| Lymphoma, Non-Hodgkin | 3 | 2022 | 1374 | 0.320 |
Why?
|
| Seasons | 3 | 2021 | 1524 | 0.310 |
Why?
|
| Leiomyoma | 2 | 2024 | 644 | 0.310 |
Why?
|
| DNA Fragmentation | 1 | 2009 | 240 | 0.310 |
Why?
|
| Cattle | 1 | 2014 | 3819 | 0.300 |
Why?
|
| Depression, Postpartum | 2 | 2023 | 355 | 0.300 |
Why?
|
| Premenopause | 5 | 2024 | 1039 | 0.300 |
Why?
|
| New York | 3 | 2016 | 882 | 0.300 |
Why?
|
| Pregnancy Trimester, Second | 3 | 2024 | 737 | 0.290 |
Why?
|
| Oleic Acid | 1 | 2008 | 90 | 0.290 |
Why?
|
| Birth Rate | 3 | 2019 | 168 | 0.290 |
Why?
|
| Michigan | 2 | 2018 | 330 | 0.280 |
Why?
|
| Depression | 10 | 2024 | 8231 | 0.280 |
Why?
|
| Demography | 4 | 2023 | 1641 | 0.280 |
Why?
|
| Poultry | 2 | 2018 | 79 | 0.280 |
Why?
|
| Texas | 2 | 2018 | 410 | 0.280 |
Why?
|
| Linoleic Acid | 1 | 2008 | 158 | 0.270 |
Why?
|
| Maternal Exposure | 3 | 2024 | 1096 | 0.270 |
Why?
|
| Embryo, Mammalian | 1 | 2012 | 1676 | 0.270 |
Why?
|
| Logistic Models | 11 | 2018 | 13289 | 0.270 |
Why?
|
| Pandemics | 9 | 2024 | 8748 | 0.260 |
Why?
|
| Nutrition Surveys | 6 | 2021 | 1738 | 0.260 |
Why?
|
| Metabolome | 4 | 2023 | 1009 | 0.260 |
Why?
|
| Prenatal Nutritional Physiological Phenomena | 2 | 2017 | 161 | 0.260 |
Why?
|
| Patient Compliance | 4 | 2019 | 2697 | 0.260 |
Why?
|
| Vitamin D | 5 | 2019 | 3311 | 0.250 |
Why?
|
| Time Factors | 17 | 2021 | 40214 | 0.250 |
Why?
|
| Solanum tuberosum | 2 | 2016 | 47 | 0.250 |
Why?
|
| Spain | 4 | 2019 | 484 | 0.240 |
Why?
|
| Risk Assessment | 15 | 2020 | 24314 | 0.240 |
Why?
|
| Milk | 3 | 2021 | 438 | 0.240 |
Why?
|
| Hyperandrogenism | 1 | 2025 | 46 | 0.240 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 2 | 2017 | 348 | 0.240 |
Why?
|
| Epidemiologic Studies | 3 | 2017 | 677 | 0.230 |
Why?
|
| Fish Oils | 2 | 2020 | 483 | 0.230 |
Why?
|
| Protective Clothing | 3 | 2020 | 103 | 0.230 |
Why?
|
| Pets | 1 | 2024 | 46 | 0.230 |
Why?
|
| Reference Values | 4 | 2016 | 4938 | 0.220 |
Why?
|
| Motor Activity | 4 | 2018 | 2711 | 0.220 |
Why?
|
| Luteinizing Hormone | 3 | 2021 | 822 | 0.220 |
Why?
|
| Lactation | 3 | 2022 | 392 | 0.220 |
Why?
|
| Aged | 33 | 2024 | 171446 | 0.220 |
Why?
|
| Bariatric Surgery | 1 | 2013 | 1003 | 0.210 |
Why?
|
| Reproducibility of Results | 7 | 2019 | 20218 | 0.210 |
Why?
|
| DNA Methylation | 3 | 2024 | 4426 | 0.210 |
Why?
|
| Ovulation Induction | 4 | 2023 | 277 | 0.210 |
Why?
|
| Food Handling | 3 | 2024 | 158 | 0.210 |
Why?
|
| Oocytes | 4 | 2023 | 1172 | 0.210 |
Why?
|
| Postpartum Period | 3 | 2024 | 1198 | 0.210 |
Why?
|
| Hair | 2 | 2017 | 508 | 0.200 |
Why?
|
| Nursing Staff, Hospital | 2 | 2017 | 350 | 0.200 |
Why?
|
| Azoospermia | 2 | 2012 | 28 | 0.200 |
Why?
|
| Oligospermia | 2 | 2012 | 59 | 0.200 |
Why?
|
| Antineoplastic Agents | 3 | 2020 | 13658 | 0.200 |
Why?
|
| CpG Islands | 2 | 2024 | 1206 | 0.200 |
Why?
|
| School Health Services | 1 | 2005 | 388 | 0.200 |
Why?
|
| Food | 2 | 2017 | 768 | 0.200 |
Why?
|
| Diet, Carbohydrate-Restricted | 2 | 2015 | 263 | 0.200 |
Why?
|
| Waist-Hip Ratio | 2 | 2020 | 520 | 0.200 |
Why?
|
| Child, Preschool | 12 | 2024 | 42665 | 0.190 |
Why?
|
| Case-Control Studies | 11 | 2022 | 22287 | 0.190 |
Why?
|
| Treatment Outcome | 21 | 2022 | 65364 | 0.190 |
Why?
|
| Pregnancy Trimester, First | 3 | 2024 | 917 | 0.190 |
Why?
|
| Azocines | 1 | 2021 | 20 | 0.190 |
Why?
|
| Pregnancy, Unplanned | 2 | 2019 | 85 | 0.190 |
Why?
|
| Reproductive Techniques | 1 | 2021 | 41 | 0.190 |
Why?
|
| Family Characteristics | 3 | 2016 | 1003 | 0.190 |
Why?
|
| Chromatography, Gas | 2 | 2012 | 150 | 0.190 |
Why?
|
| Food, Organic | 2 | 2018 | 34 | 0.180 |
Why?
|
| Boston | 9 | 2023 | 9368 | 0.180 |
Why?
|
| Academic Medical Centers | 5 | 2017 | 2783 | 0.180 |
Why?
|
| Prenatal Care | 2 | 2018 | 1162 | 0.170 |
Why?
|
| Gonadal Hormones | 1 | 2020 | 29 | 0.170 |
Why?
|
| Calcium, Dietary | 2 | 2013 | 533 | 0.170 |
Why?
|
| Ownership | 1 | 2022 | 338 | 0.170 |
Why?
|
| Tea | 2 | 2024 | 290 | 0.170 |
Why?
|
| Singapore | 1 | 2021 | 300 | 0.170 |
Why?
|
| Insulin-Like Growth Factor II | 1 | 2021 | 271 | 0.170 |
Why?
|
| Metals | 1 | 2024 | 713 | 0.170 |
Why?
|
| Nitrogen Dioxide | 2 | 2020 | 534 | 0.170 |
Why?
|
| Amenorrhea | 1 | 2023 | 484 | 0.170 |
Why?
|
| Parents | 3 | 2024 | 3595 | 0.170 |
Why?
|
| Magnesium | 2 | 2013 | 815 | 0.160 |
Why?
|
| Trihalomethanes | 1 | 2019 | 49 | 0.160 |
Why?
|
| Genomic Imprinting | 1 | 2021 | 326 | 0.160 |
Why?
|
| North America | 1 | 2023 | 1289 | 0.160 |
Why?
|
| Obesity, Abdominal | 2 | 2021 | 375 | 0.160 |
Why?
|
| Hand Strength | 1 | 2022 | 466 | 0.160 |
Why?
|
| Erythrocyte Membrane | 1 | 2020 | 438 | 0.160 |
Why?
|
| Sex Hormone-Binding Globulin | 4 | 2020 | 553 | 0.160 |
Why?
|
| Benzophenones | 1 | 2019 | 57 | 0.160 |
Why?
|
| Health Surveys | 3 | 2021 | 4056 | 0.160 |
Why?
|
| Sex Offenses | 1 | 2023 | 357 | 0.160 |
Why?
|
| Vaccination | 2 | 2022 | 3437 | 0.160 |
Why?
|
| Prevalence | 5 | 2025 | 15867 | 0.160 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2016 | 10396 | 0.150 |
Why?
|
| Animals | 21 | 2024 | 169222 | 0.150 |
Why?
|
| Shellfish | 2 | 2018 | 37 | 0.150 |
Why?
|
| Estradiol | 6 | 2023 | 1951 | 0.150 |
Why?
|
| Sterilization, Tubal | 1 | 2018 | 78 | 0.150 |
Why?
|
| Breast Feeding | 6 | 2024 | 1363 | 0.150 |
Why?
|
| Sunscreening Agents | 1 | 2019 | 139 | 0.150 |
Why?
|
| Epigenesis, Genetic | 2 | 2024 | 3834 | 0.150 |
Why?
|
| Carbohydrates | 1 | 2020 | 389 | 0.150 |
Why?
|
| Education, Continuing | 1 | 2019 | 115 | 0.150 |
Why?
|
| Iron | 1 | 2006 | 1813 | 0.150 |
Why?
|
| Progesterone | 3 | 2020 | 752 | 0.150 |
Why?
|
| Nursing | 1 | 2017 | 35 | 0.140 |
Why?
|
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 249 | 0.140 |
Why?
|
| Severity of Illness Index | 5 | 2021 | 15944 | 0.140 |
Why?
|
| Automobiles | 1 | 2018 | 103 | 0.140 |
Why?
|
| Nutrition Policy | 1 | 2021 | 467 | 0.140 |
Why?
|
| Health Behavior | 5 | 2024 | 2650 | 0.140 |
Why?
|
| Vitamin D Deficiency | 2 | 2017 | 1388 | 0.140 |
Why?
|
| Spermatogenesis | 2 | 2019 | 260 | 0.140 |
Why?
|
| Cell Shape | 2 | 2015 | 371 | 0.140 |
Why?
|
| Intrauterine Devices | 1 | 2018 | 115 | 0.140 |
Why?
|
| Interviews as Topic | 2 | 2018 | 2741 | 0.140 |
Why?
|
| Contraception Behavior | 1 | 2019 | 186 | 0.140 |
Why?
|
| Hyperlipidemias | 1 | 2022 | 772 | 0.140 |
Why?
|
| Sarcopenia | 1 | 2022 | 378 | 0.140 |
Why?
|
| Insemination, Artificial | 2 | 2014 | 99 | 0.140 |
Why?
|
| National Cancer Institute (U.S.) | 2 | 2016 | 300 | 0.140 |
Why?
|
| Sperm-Ovum Interactions | 1 | 2016 | 24 | 0.140 |
Why?
|
| Habits | 1 | 2017 | 148 | 0.140 |
Why?
|
| Nutritional Physiological Phenomena | 1 | 2018 | 360 | 0.140 |
Why?
|
| Reproductive Behavior | 1 | 2016 | 27 | 0.140 |
Why?
|
| Ozone | 1 | 2020 | 496 | 0.140 |
Why?
|
| Anthropometry | 1 | 2021 | 1346 | 0.140 |
Why?
|
| Folic Acid Deficiency | 1 | 2017 | 117 | 0.140 |
Why?
|
| Sulfones | 1 | 2019 | 448 | 0.140 |
Why?
|
| Interleukin-6 | 2 | 2017 | 3228 | 0.140 |
Why?
|
| Men's Health | 1 | 2017 | 75 | 0.140 |
Why?
|
| 25-Hydroxyvitamin D 2 | 1 | 2016 | 40 | 0.140 |
Why?
|
| Ovary | 1 | 2021 | 965 | 0.130 |
Why?
|
| Family Planning Services | 1 | 2019 | 279 | 0.130 |
Why?
|
| Inflammation | 5 | 2021 | 10871 | 0.130 |
Why?
|
| Energy Intake | 5 | 2024 | 2145 | 0.130 |
Why?
|
| Pregnancy Complications, Neoplastic | 1 | 2019 | 260 | 0.130 |
Why?
|
| American Heart Association | 1 | 2021 | 1050 | 0.130 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 2022 | 1149 | 0.130 |
Why?
|
| Dyslipidemias | 1 | 2024 | 873 | 0.130 |
Why?
|
| Particulate Matter | 4 | 2023 | 2617 | 0.130 |
Why?
|
| Survival Rate | 3 | 2015 | 12828 | 0.130 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2018 | 454 | 0.130 |
Why?
|
| Glycemic Index | 3 | 2022 | 400 | 0.130 |
Why?
|
| Phytoestrogens | 1 | 2016 | 59 | 0.130 |
Why?
|
| Carotid Artery Diseases | 1 | 2022 | 879 | 0.130 |
Why?
|
| Leptin | 2 | 2024 | 1599 | 0.130 |
Why?
|
| Stress, Psychological | 4 | 2022 | 4530 | 0.130 |
Why?
|
| Water Pollutants, Chemical | 1 | 2019 | 359 | 0.130 |
Why?
|
| Dietary Sucrose | 1 | 2017 | 242 | 0.130 |
Why?
|
| Circadian Rhythm | 2 | 2024 | 2591 | 0.130 |
Why?
|
| Contraception | 1 | 2019 | 362 | 0.130 |
Why?
|
| Fatty Acids, Omega-6 | 1 | 2017 | 225 | 0.130 |
Why?
|
| Calcifediol | 1 | 2016 | 160 | 0.120 |
Why?
|
| Phlebotomy | 1 | 2016 | 138 | 0.120 |
Why?
|
| Immunoenzyme Techniques | 1 | 2018 | 1698 | 0.120 |
Why?
|
| Estrogens, Non-Steroidal | 1 | 2015 | 52 | 0.120 |
Why?
|
| Ubiquinone | 1 | 2016 | 181 | 0.120 |
Why?
|
| Beer | 1 | 2015 | 135 | 0.120 |
Why?
|
| Iron, Dietary | 1 | 2016 | 148 | 0.120 |
Why?
|
| C-Reactive Protein | 2 | 2017 | 3858 | 0.120 |
Why?
|
| Wine | 1 | 2015 | 172 | 0.120 |
Why?
|
| Androstanes | 1 | 2014 | 20 | 0.120 |
Why?
|
| Women, Working | 1 | 2015 | 86 | 0.120 |
Why?
|
| Diet, Fat-Restricted | 2 | 2014 | 328 | 0.120 |
Why?
|
| Temperature | 1 | 2021 | 2234 | 0.120 |
Why?
|
| Blastocyst | 1 | 2017 | 433 | 0.120 |
Why?
|
| Regression Analysis | 5 | 2017 | 6339 | 0.120 |
Why?
|
| Triglycerides | 1 | 2022 | 2463 | 0.110 |
Why?
|
| Chi-Square Distribution | 2 | 2017 | 3435 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2019 | 998 | 0.110 |
Why?
|
| Growth | 1 | 2016 | 366 | 0.110 |
Why?
|
| Fertility Agents, Female | 1 | 2014 | 101 | 0.110 |
Why?
|
| Fibroblast Growth Factors | 1 | 2019 | 873 | 0.110 |
Why?
|
| Adolescent Development | 1 | 2017 | 276 | 0.110 |
Why?
|
| Abortion, Induced | 1 | 2019 | 471 | 0.110 |
Why?
|
| Government Programs | 1 | 2016 | 278 | 0.110 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2014 | 10757 | 0.110 |
Why?
|
| Iron Overload | 1 | 2016 | 245 | 0.110 |
Why?
|
| Occupational Health | 2 | 2017 | 812 | 0.110 |
Why?
|
| Congenital Abnormalities | 1 | 2018 | 703 | 0.110 |
Why?
|
| Thyroid Gland | 1 | 2020 | 1172 | 0.110 |
Why?
|
| Cholesterol, Dietary | 1 | 2014 | 224 | 0.110 |
Why?
|
| Cheese | 1 | 2013 | 39 | 0.110 |
Why?
|
| Insulin | 4 | 2021 | 6606 | 0.110 |
Why?
|
| Bayes Theorem | 4 | 2023 | 2358 | 0.110 |
Why?
|
| Aged, 80 and over | 9 | 2021 | 59598 | 0.110 |
Why?
|
| Housing | 1 | 2018 | 683 | 0.110 |
Why?
|
| Sleep | 3 | 2024 | 4817 | 0.100 |
Why?
|
| Cholesterol | 1 | 2022 | 2914 | 0.100 |
Why?
|
| Fatty Liver | 1 | 2019 | 809 | 0.100 |
Why?
|
| Metabolic Diseases | 1 | 2019 | 684 | 0.100 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 3115 | 0.100 |
Why?
|
| Vitamin B 12 | 1 | 2015 | 529 | 0.100 |
Why?
|
| Risk Adjustment | 1 | 2016 | 599 | 0.100 |
Why?
|
| Research | 2 | 2023 | 1979 | 0.100 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 3238 | 0.100 |
Why?
|
| Retrospective Studies | 9 | 2022 | 81746 | 0.100 |
Why?
|
| Central Nervous System Stimulants | 2 | 2018 | 1168 | 0.100 |
Why?
|
| Oxidative Stress | 2 | 2020 | 3140 | 0.100 |
Why?
|
| Asthma | 3 | 2024 | 6273 | 0.100 |
Why?
|
| Hot Temperature | 1 | 2018 | 1441 | 0.100 |
Why?
|
| Fast Foods | 2 | 2024 | 219 | 0.090 |
Why?
|
| Neoplasms, Glandular and Epithelial | 1 | 2015 | 489 | 0.090 |
Why?
|
| Meta-Analysis as Topic | 1 | 2016 | 1363 | 0.090 |
Why?
|
| Gestational Age | 2 | 2019 | 3622 | 0.090 |
Why?
|
| Leisure Activities | 1 | 2013 | 310 | 0.090 |
Why?
|
| Neuropsychological Tests | 1 | 2024 | 7140 | 0.090 |
Why?
|
| Polymorphism, Single Nucleotide | 5 | 2020 | 16041 | 0.090 |
Why?
|
| Age Factors | 6 | 2024 | 18407 | 0.090 |
Why?
|
| Diet, Reducing | 1 | 2014 | 487 | 0.090 |
Why?
|
| Heart | 1 | 2024 | 4444 | 0.090 |
Why?
|
| Androgens | 1 | 2018 | 1281 | 0.090 |
Why?
|
| Health Status | 1 | 2023 | 4092 | 0.090 |
Why?
|
| Colombia | 3 | 2009 | 287 | 0.090 |
Why?
|
| Gloves, Protective | 2 | 2020 | 23 | 0.090 |
Why?
|
| Glucose Intolerance | 1 | 2014 | 579 | 0.090 |
Why?
|
| Fetal Macrosomia | 2 | 2024 | 138 | 0.090 |
Why?
|
| Health Personnel | 2 | 2021 | 3385 | 0.090 |
Why?
|
| Mortality | 1 | 2021 | 2910 | 0.080 |
Why?
|
| Loneliness | 2 | 2022 | 211 | 0.080 |
Why?
|
| Osmolar Concentration | 1 | 2010 | 657 | 0.080 |
Why?
|
| Physical Examination | 1 | 2016 | 1263 | 0.080 |
Why?
|
| Skinfold Thickness | 2 | 2009 | 164 | 0.080 |
Why?
|
| Age Distribution | 3 | 2017 | 2871 | 0.080 |
Why?
|
| Hypothyroidism | 1 | 2014 | 667 | 0.080 |
Why?
|
| Child Nutrition Sciences | 1 | 2009 | 22 | 0.080 |
Why?
|
| Guideline Adherence | 2 | 2016 | 2235 | 0.080 |
Why?
|
| Dementia | 1 | 2024 | 2740 | 0.080 |
Why?
|
| Ethanol | 1 | 2015 | 1331 | 0.080 |
Why?
|
| Disease Progression | 5 | 2019 | 13665 | 0.080 |
Why?
|
| Metabolomics | 1 | 2018 | 1674 | 0.080 |
Why?
|
| Contraceptive Agents | 2 | 2020 | 148 | 0.080 |
Why?
|
| Recurrence | 1 | 2021 | 8507 | 0.080 |
Why?
|
| Ohio | 1 | 2009 | 321 | 0.080 |
Why?
|
| Heart Diseases | 1 | 2021 | 2819 | 0.080 |
Why?
|
| Republic of Korea | 2 | 2023 | 591 | 0.080 |
Why?
|
| Quantitative Trait Loci | 1 | 2016 | 2131 | 0.080 |
Why?
|
| Specimen Handling | 1 | 2013 | 708 | 0.070 |
Why?
|
| Sex Factors | 4 | 2019 | 10627 | 0.070 |
Why?
|
| Nutritive Value | 2 | 2021 | 351 | 0.070 |
Why?
|
| Papillomavirus Infections | 1 | 2020 | 1640 | 0.070 |
Why?
|
| Pregnancy Trimester, Third | 2 | 2024 | 587 | 0.070 |
Why?
|
| Ambulatory Care Facilities | 2 | 2017 | 939 | 0.070 |
Why?
|
| Inhibins | 2 | 2020 | 210 | 0.070 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2020 | 4055 | 0.070 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2020 | 2043 | 0.070 |
Why?
|
| Socioeconomic Factors | 4 | 2021 | 7851 | 0.070 |
Why?
|
| Medical Records | 2 | 2017 | 1409 | 0.070 |
Why?
|
| Genome-Wide Association Study | 4 | 2024 | 12795 | 0.070 |
Why?
|
| Interdisciplinary Communication | 1 | 2013 | 937 | 0.070 |
Why?
|
| Glioma | 1 | 2022 | 3503 | 0.070 |
Why?
|
| Genetic Predisposition to Disease | 5 | 2022 | 18062 | 0.070 |
Why?
|
| Lipids | 3 | 2024 | 3342 | 0.070 |
Why?
|
| Telemedicine | 2 | 2024 | 3109 | 0.070 |
Why?
|
| Drug Administration Schedule | 1 | 2014 | 4857 | 0.070 |
Why?
|
| Video Games | 1 | 2009 | 202 | 0.070 |
Why?
|
| Postmenopause | 1 | 2015 | 2518 | 0.070 |
Why?
|
| Atherosclerosis | 1 | 2022 | 3433 | 0.070 |
Why?
|
| Fetal Blood | 2 | 2024 | 1361 | 0.070 |
Why?
|
| Homicide | 1 | 2009 | 294 | 0.070 |
Why?
|
| Bacteria | 1 | 2017 | 2216 | 0.070 |
Why?
|
| Health Promotion | 1 | 2018 | 2210 | 0.060 |
Why?
|
| Biomedical Research | 2 | 2019 | 3463 | 0.060 |
Why?
|
| Predictive Value of Tests | 3 | 2017 | 15442 | 0.060 |
Why?
|
| Software | 1 | 2020 | 4478 | 0.060 |
Why?
|
| Energy Metabolism | 2 | 2016 | 2908 | 0.060 |
Why?
|
| Analysis of Variance | 1 | 2014 | 6228 | 0.060 |
Why?
|
| Dietary Fats, Unsaturated | 1 | 2007 | 222 | 0.060 |
Why?
|
| Administration, Oral | 1 | 2013 | 4030 | 0.060 |
Why?
|
| Maternal Age | 2 | 2020 | 805 | 0.060 |
Why?
|
| Food Supply | 1 | 2011 | 544 | 0.060 |
Why?
|
| Body Height | 2 | 2016 | 1565 | 0.060 |
Why?
|
| Survival Analysis | 2 | 2015 | 10098 | 0.060 |
Why?
|
| Physician-Patient Relations | 1 | 2018 | 3269 | 0.060 |
Why?
|
| Eicosapentaenoic Acid | 2 | 2022 | 565 | 0.060 |
Why?
|
| Mental Disorders | 1 | 2024 | 6875 | 0.060 |
Why?
|
| Thyrotropin | 2 | 2020 | 835 | 0.060 |
Why?
|
| Prognosis | 5 | 2019 | 29979 | 0.060 |
Why?
|
| Social Environment | 1 | 2009 | 1012 | 0.060 |
Why?
|
| Agriculture | 1 | 2005 | 186 | 0.060 |
Why?
|
| PPAR gamma | 1 | 2007 | 485 | 0.060 |
Why?
|
| Combined Modality Therapy | 2 | 2014 | 8535 | 0.060 |
Why?
|
| Gonadotropins | 2 | 2015 | 241 | 0.060 |
Why?
|
| Comorbidity | 4 | 2022 | 10590 | 0.050 |
Why?
|
| China | 2 | 2019 | 2395 | 0.050 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2019 | 8637 | 0.050 |
Why?
|
| Infant | 6 | 2020 | 36534 | 0.050 |
Why?
|
| Taiwan | 1 | 2024 | 521 | 0.050 |
Why?
|
| Soil | 1 | 2023 | 120 | 0.050 |
Why?
|
| Placebos | 1 | 2007 | 1667 | 0.050 |
Why?
|
| Pilot Projects | 2 | 2020 | 8740 | 0.050 |
Why?
|
| Violence | 1 | 2009 | 933 | 0.050 |
Why?
|
| Health Status Disparities | 2 | 2024 | 1885 | 0.050 |
Why?
|
| Phosphatidylcholines | 1 | 2024 | 406 | 0.050 |
Why?
|
| Choline | 1 | 2024 | 522 | 0.050 |
Why?
|
| Myocardial Infarction | 1 | 2023 | 11519 | 0.050 |
Why?
|
| Environmental Monitoring | 2 | 2019 | 1469 | 0.050 |
Why?
|
| Stroke | 1 | 2024 | 9755 | 0.050 |
Why?
|
| Data Interpretation, Statistical | 2 | 2009 | 2708 | 0.050 |
Why?
|
| Child Abuse, Sexual | 1 | 2024 | 400 | 0.050 |
Why?
|
| Biological Clocks | 1 | 2024 | 321 | 0.050 |
Why?
|
| Object Attachment | 1 | 2024 | 326 | 0.050 |
Why?
|
| France | 2 | 2012 | 497 | 0.050 |
Why?
|
| Drug Combinations | 1 | 2007 | 2089 | 0.050 |
Why?
|
| C-Peptide | 1 | 2022 | 443 | 0.050 |
Why?
|
| Missouri | 1 | 2020 | 113 | 0.040 |
Why?
|
| Adult Survivors of Child Abuse | 1 | 2024 | 301 | 0.040 |
Why?
|
| Neoplasm Staging | 1 | 2015 | 11221 | 0.040 |
Why?
|
| Plants | 1 | 2021 | 332 | 0.040 |
Why?
|
| Glutens | 1 | 2022 | 240 | 0.040 |
Why?
|
| Algorithms | 1 | 2020 | 14163 | 0.040 |
Why?
|
| Latin America | 1 | 2021 | 416 | 0.040 |
Why?
|
| Chorionic Gonadotropin, beta Subunit, Human | 1 | 2019 | 83 | 0.040 |
Why?
|
| Feasibility Studies | 1 | 2010 | 5314 | 0.040 |
Why?
|
| Hysterectomy | 1 | 2024 | 863 | 0.040 |
Why?
|
| Practice Guidelines as Topic | 1 | 2016 | 7445 | 0.040 |
Why?
|
| Prostate | 1 | 2007 | 1765 | 0.040 |
Why?
|
| Dogs | 1 | 2024 | 3844 | 0.040 |
Why?
|
| Reproductive Health Services | 1 | 2019 | 90 | 0.040 |
Why?
|
| Iodide Peroxidase | 1 | 2020 | 295 | 0.040 |
Why?
|
| Ovarian Neoplasms | 1 | 2015 | 4915 | 0.040 |
Why?
|
| Dental Health Surveys | 1 | 2018 | 39 | 0.040 |
Why?
|
| Women | 1 | 2020 | 225 | 0.040 |
Why?
|
| Selection, Genetic | 1 | 2023 | 877 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2013 | 14718 | 0.040 |
Why?
|
| Sweden | 1 | 2021 | 1382 | 0.040 |
Why?
|
| Pregnancy in Adolescence | 1 | 2019 | 166 | 0.040 |
Why?
|
| Carnitine | 1 | 2019 | 253 | 0.040 |
Why?
|
| Plasma | 1 | 2021 | 584 | 0.040 |
Why?
|
| Aspartate Aminotransferases | 1 | 2019 | 414 | 0.040 |
Why?
|
| Workplace | 1 | 2024 | 873 | 0.040 |
Why?
|
| Cell Count | 1 | 2021 | 1831 | 0.040 |
Why?
|
| Climate | 1 | 2018 | 146 | 0.040 |
Why?
|
| New England | 1 | 2020 | 1058 | 0.040 |
Why?
|
| Principal Component Analysis | 1 | 2020 | 948 | 0.040 |
Why?
|
| Thyroid Hormones | 1 | 2020 | 408 | 0.040 |
Why?
|
| Vaginal Smears | 1 | 2020 | 505 | 0.030 |
Why?
|
| Eggs | 1 | 2018 | 182 | 0.030 |
Why?
|
| Adipose Tissue | 1 | 2009 | 3329 | 0.030 |
Why?
|
| Respiratory Protective Devices | 1 | 2017 | 47 | 0.030 |
Why?
|
| Age of Onset | 2 | 2017 | 3347 | 0.030 |
Why?
|
| Walking | 1 | 2024 | 1201 | 0.030 |
Why?
|
| Alanine Transaminase | 1 | 2019 | 606 | 0.030 |
Why?
|
| Adolescent Nutritional Physiological Phenomena | 1 | 2016 | 62 | 0.030 |
Why?
|
| Endometrium | 1 | 2019 | 406 | 0.030 |
Why?
|
| Immunoassay | 1 | 2019 | 746 | 0.030 |
Why?
|
| Geography | 1 | 2018 | 652 | 0.030 |
Why?
|
| Public Health | 2 | 2020 | 2679 | 0.030 |
Why?
|
| Ultrasonography | 2 | 2021 | 6004 | 0.030 |
Why?
|
| Poisson Distribution | 1 | 2017 | 506 | 0.030 |
Why?
|
| Uterine Neoplasms | 1 | 2024 | 1424 | 0.030 |
Why?
|
| Adult Children | 1 | 2016 | 104 | 0.030 |
Why?
|
| Biological Specimen Banks | 1 | 2021 | 788 | 0.030 |
Why?
|
| Breast Neoplasms | 1 | 2023 | 21206 | 0.030 |
Why?
|
| Pectinidae | 1 | 2015 | 5 | 0.030 |
Why?
|
| Chromatography, Liquid | 1 | 2019 | 996 | 0.030 |
Why?
|
| Canada | 1 | 2021 | 2129 | 0.030 |
Why?
|
| Research Support as Topic | 1 | 2019 | 696 | 0.030 |
Why?
|
| Docosahexaenoic Acids | 1 | 2022 | 914 | 0.030 |
Why?
|
| Hydrocarbons, Chlorinated | 1 | 2016 | 120 | 0.030 |
Why?
|
| Organophosphorus Compounds | 1 | 2016 | 211 | 0.030 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2020 | 746 | 0.030 |
Why?
|
| Physicians | 1 | 2012 | 4598 | 0.030 |
Why?
|
| Stearic Acids | 1 | 2014 | 56 | 0.030 |
Why?
|
| Mother-Child Relations | 1 | 2018 | 498 | 0.030 |
Why?
|
| Clomiphene | 1 | 2014 | 72 | 0.030 |
Why?
|
| Heme | 1 | 2016 | 316 | 0.030 |
Why?
|
| Internal-External Control | 1 | 2015 | 348 | 0.030 |
Why?
|
| Mendelian Randomization Analysis | 1 | 2019 | 1040 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2019 | 1904 | 0.030 |
Why?
|
| Family Health | 1 | 2018 | 1255 | 0.030 |
Why?
|
| Vital Capacity | 1 | 2016 | 996 | 0.030 |
Why?
|
| Cross-Over Studies | 1 | 2019 | 2107 | 0.030 |
Why?
|
| Cell Membrane | 1 | 2022 | 3657 | 0.030 |
Why?
|
| Phenotype | 2 | 2024 | 16723 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2007 | 12464 | 0.030 |
Why?
|
| Drug Utilization Review | 1 | 2014 | 248 | 0.030 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2019 | 1197 | 0.030 |
Why?
|
| Endpoint Determination | 1 | 2015 | 592 | 0.030 |
Why?
|
| Child Behavior | 1 | 2018 | 864 | 0.030 |
Why?
|
| Sex Distribution | 1 | 2017 | 2276 | 0.030 |
Why?
|
| Minority Groups | 1 | 2019 | 1217 | 0.020 |
Why?
|
| Autoimmunity | 1 | 2020 | 1361 | 0.020 |
Why?
|
| Curriculum | 1 | 2005 | 3782 | 0.020 |
Why?
|
| Organ Size | 1 | 2017 | 2267 | 0.020 |
Why?
|
| Epidemiologic Methods | 1 | 2016 | 1326 | 0.020 |
Why?
|
| Financing, Personal | 1 | 2014 | 310 | 0.020 |
Why?
|
| Particle Size | 1 | 2016 | 1649 | 0.020 |
Why?
|
| Glucose Tolerance Test | 1 | 2014 | 1181 | 0.020 |
Why?
|
| Workload | 1 | 2017 | 849 | 0.020 |
Why?
|
| Forced Expiratory Volume | 1 | 2016 | 1831 | 0.020 |
Why?
|
| Employment | 1 | 2017 | 1110 | 0.020 |
Why?
|
| Universities | 1 | 2015 | 1005 | 0.020 |
Why?
|
| Immunoglobulin E | 1 | 2016 | 1497 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2024 | 9384 | 0.020 |
Why?
|
| Epidemiologic Research Design | 1 | 2013 | 368 | 0.020 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2013 | 794 | 0.020 |
Why?
|
| Sexual Development | 1 | 2009 | 39 | 0.020 |
Why?
|
| Gastrointestinal Diseases | 1 | 2017 | 1207 | 0.020 |
Why?
|
| Economics | 1 | 2009 | 141 | 0.020 |
Why?
|
| Colorectal Neoplasms | 1 | 2008 | 6973 | 0.020 |
Why?
|
| Residence Characteristics | 1 | 2018 | 2118 | 0.020 |
Why?
|
| Adolescent Behavior | 1 | 2016 | 1188 | 0.020 |
Why?
|
| Models, Theoretical | 1 | 2019 | 3573 | 0.020 |
Why?
|
| Alleles | 1 | 2018 | 6894 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2019 | 9556 | 0.020 |
Why?
|
| Health Care Surveys | 1 | 2014 | 2433 | 0.020 |
Why?
|
| Mexico | 1 | 2009 | 769 | 0.020 |
Why?
|
| Cooperative Behavior | 1 | 2013 | 1512 | 0.020 |
Why?
|
| Income | 1 | 2014 | 1878 | 0.020 |
Why?
|
| Hospitals | 1 | 2018 | 3886 | 0.020 |
Why?
|
| Genetic Variation | 1 | 2019 | 6611 | 0.010 |
Why?
|
| Health Services Accessibility | 1 | 2021 | 5520 | 0.010 |
Why?
|
| Aging | 1 | 2023 | 8744 | 0.010 |
Why?
|
| Models, Biological | 1 | 2020 | 9493 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2019 | 10470 | 0.010 |
Why?
|
| Video Recording | 1 | 2009 | 976 | 0.010 |
Why?
|
| Genotype | 1 | 2018 | 13042 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2019 | 17128 | 0.010 |
Why?
|
| Insurance Coverage | 1 | 2014 | 1946 | 0.010 |
Why?
|
| Hospitalization | 1 | 2022 | 10840 | 0.010 |
Why?
|
| Patient Selection | 1 | 2010 | 4258 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2013 | 8052 | 0.010 |
Why?
|